logo
logo

Tempus acquires Paige for $81.25 million

Aug 22, 2025•2 months ago

Acquiring Company

Tempus

Acquired Company

Paige

ChicagoNew YorkBiotechnologySoftware

Description

Tempus has announced the acquisition of Paige for $81.25 million, primarily in Tempus common stock. This acquisition enhances Tempus's capabilities in digital pathology and expands its dataset significantly. Paige brings a proven technology portfolio and strong expertise in AI applications for cancer detection. The merger is expected to accelerate Tempus's efforts in precision medicine.

Company Information

Company

Tempus

Location

Chicago, Illinois, United States

About

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make near real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit www.tempus.com.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed